Abstract
Socioeconomic differences appear to be reflected in both, the development and the treatment of common mental disorders (CMDs, i.e. depressive, anxiety and stress-related disorders). Underlying mechanisms of these inequalities are to date not fully understood. This study aimed to investigate if (1) there are socioeconomic differences with regard to type of treatment and (2) if the socioeconomic status modifies the association between treatment and subsequent inpatient care or suicide attempt, respectively, in individuals with CMDs. The study population comprised 66,097 individuals aged 18-59 on sick-leave due to a CMD during 2006 in Sweden. Cox regression with a follow-up from 2007 through 2010 estimated crude and multivariate hazard ratios (HR) with 95% confidence intervals (CI). Individuals with sickness absence due to CMDs and a higher educational level were had a lower proportions of specialised health care and combined psychiatric medication than their counterparts with lower education. However, if high educated CMD patients received more combined medication, associations with subsequent mental inpatient care (p < 0.01) and suicide attempt (p < 0.05) were stronger than for their counterparts with low education. Moreover, pr...Continue Reading
References
Sep 1, 1991·Scandinavian Journal of Social Medicine·L O Ljungdahl, P Bjurulf
Mar 15, 2000·Journal of Epidemiology and Community Health·M BobákM Marmot
Jan 11, 2003·American Journal of Epidemiology·V LorantM Ansseau
Apr 30, 2003·Social Psychiatry and Psychiatric Epidemiology·Tom FryersRachel Jenkins
Oct 11, 2005·Social Psychiatry and Psychiatric Epidemiology·Matthias C AngermeyerHerbert Matschinger
Feb 10, 2006·Acta Psychiatrica Scandinavica·M C Angermeyer, S Dietrich
Nov 11, 2006·Occupational and Environmental Medicine·Christine SolomonDavid Coggon
Aug 13, 2008·European Journal of Clinical Pharmacology·Syed Imran HaiderJohan Fastbom
May 12, 2011·Journal of the Royal Society of Medicine·M HendersonM Hotopf
May 26, 2011·BMJ : British Medical Journal·Stephen PillingUNKNOWN Guideline Development Group
Jun 11, 2011·BMC Public Health·Jonas F LudvigssonPetra Otterblad Olausson
Oct 5, 2011·Journal of Epidemiology and Community Health·Simon de LusignanTony Kendrick
Apr 14, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Markus JokelaMika Kivimäki
Oct 11, 2012·PloS One·Ellenor Mittendorfer-RutzKristina Alexanderson
Feb 12, 2013·Journal of Affective Disorders·Peter ButterworthLiana S Leach
Feb 19, 2013·BMC Public Health·Felix WedegaertnerWilliam E Lee
May 22, 2013·BMC Public Health·Kazi Ishtiak-AhmedEllenor Mittendorfer-Rutz
Sep 3, 2013·Lancet·Harvey A WhitefordTheo Vos
Oct 22, 2013·Occupational and Environmental Medicine·Mo WangEllenor Mittendorfer-Rutz
Jun 26, 2014·PloS One·Ellenor Mittendorfer-RutzJari Haukka
Aug 20, 2014·International Review of Psychiatry·Jessica AllenMichael Marmot
Dec 24, 2014·Acta Psychiatrica Scandinavica·J W WastessonK Johnell
Feb 24, 2015·European Journal of Pain : EJP·T E DornerE Mittendorfer-Rutz
Aug 28, 2015·Journal of Health Communication·Samuel G SmithCarol J Simon
Oct 16, 2015·Psychological Medicine·T E DornerE Mittendorfer-Rutz
Mar 21, 2017·BMJ Open·Laura WerlenEllenor Mittendorfer-Rutz
Mar 30, 2017·European Journal of Public Health·Ellen VerbakelTerje A Eikemo